27 Feb 2023
Five companies awarded up to £20,000 of funding through the Research and Innovation (R&I) Health Accelerator Follow-On Innovation Voucher
Five companies have been awarded up to £20,000 of funding each to support collaborative projects to progress towards key adoption and commercialisation milestones, through the Research & Innovation (R&I) Health Accelerator Follow-On Innovation Voucher.
The Research and Innovation (R&I) Health Accelerator is an ERDF (European Regional Development Fund) part-funded project delivered by Health Innovation Manchester, The University of Manchester, The University of Manchester Innovation Factory, Manchester City Council and Bionow.
The programme supports SMEs who may be at various stages of their journey to navigate the health and care system, develop value propositions, ethics and regulatory advice, and gain access to university-wide expertise.
As part of the support provided via the programme, SMEs with the potential to introduce new innovations to market are provided with opportunities for in-depth collaboration with researchers and other stakeholders, before being able to apply for collaborative support funding via the Follow-On Voucher Award and the Small Innovation Voucher.
The Follow-On Innovation Voucher Award of up to £20,000 received a total of ten applications from companies registered to the ERDF R&I Health Accelerator programme. The companies were selected by a panel of representatives from Health Innovation Manchester, The Christabel Pankhurst Institute and the University of Manchester Innovation Factory.
The five successful companies are:
To date, The ERDF R&I Health Accelerator has supported over 60 SMEs to accelerate the development and improve commercialisation of innovative healthcare products and services within life sciences.
The programme demonstrates how Health Innovation Manchester works with SMEs to discover, develop, and deploy new innovations into the Greater Manchester health and social care system, and highlights the breadth of innovation activity taking place across the region.
Programme support for the five listed innovations through the R&I Health Accelerator programme will come to an end in June 2023.
In addition to this piece of work the University of Manchester has also awarded funding of up to £24,000 each to SMEs through the PDRA Funding Awards. These research collaboration grants have been awarded to ten SMEs as part of the ERDF R&I Health Accelerator programme. The three companies who have recently been awarded PDRA Funding Awards are (click each tab below to read more):
Viscgo is a MedTech based in Manchester has been founded specifically to address an unmet need in the management of dysphagia (swallowing difficulty) and to develop practical ways to ensure that food and drink are modified to the correct prescribed texture for each person with dysphagia.
Optasia Medical is based in Stockport, develops and provides technology for Fracture Liaison Services and bone health teams to support clinicians and patients in the secondary fracture prevention pathway for patients diagnosed with osteoporosis following a fragility fracture.
Innovate Pharmaceuticals based in Manchester is an early-stage pharmaceutical development company that has developed a unique platform to fully solubilise previously difficult to solubilise pharmaceutical molecules. The collaboration will focus on understanding the behaviour of drugs in a novel liquid platform technology in terms of degradation and stability.